Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-02-20Clinical Trial Update: Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer [Phase 3]
Phase 3 trial update for bevacizumab in metastatic colorectal cancer after first-line therapy has terminated.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO) [Phase 3]
Phase III trial update for Fruquintinib in multilined colorectal cancer completed.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Phase Ib Study of Fruquintinib in 3rd Line mCRC [Phase 1, Phase 2]
Phase Ib/Phase II trial update of Fruquintinib in third-line colorectal cancer shows completed status.
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Single Incision Plus One Port Laparoscopic Surgery Assistant Enhanced Recovery After Surgery on Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating single incision plus one port laparoscopic surgery with enhanced recovery after surgery for colorectal can…
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Low Dose Metronomic Poly-chemotherapy for Metastatic CRC [Phase 2]
A Phase 2 trial evaluates low-dose metronomic poly-chemotherapy for metastatic colorectal cancer and has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial results for capecitabine and bevacizumab with or without atezolizumab in patients with refractory metastatic colorectal cancer…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection [NA]
Clinical trial update for TAP block analgesia after laparoscopic colectomy has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC [Phase 3]
Phase 3 trial comparing Folfoxiri plus Bev reintroduction at progression versus Folfox plus Bev followed by Folfiri plus Bev in metastatic c…
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer [Phase 1, Phase 2]
A Phase 1/2 trial assessing the combination of curcumin with FOLFOX chemotherapy in patients with inoperable colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer [Phase 1, Phase 2]
Phase 1/2 trial update for an experimental in-situ cancer vaccine across multiple solid tumors, including breast, colorectal, prostate, mela…
-
CLINICAL_TRIALS withdrawal · 2020-01-22Clinical Trial Update: AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer [Phase 2, Phase 3]
Clinical trial for AlloStim in-situ vaccine in pre-treated metastatic colorectal cancer has been withdrawn from both Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Quell Opioid Reduction and Pain Relief in Patients With Cancer [NA]
A terminated clinical trial update for Quell opioid reduction and pain relief in cancer patients, with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas [Phase 2]
Phase 2 trial update for Abraxane in CIMP-High colorectal and small bowel adenocarcinomas; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Navigation From Community to Clinic to Promote CRC Screening in Underserved Populations [NA]
Clinical trial update on promoting colorectal cancer screening in underserved populations; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Apatinib in Refractory Colorectal Cancer [Phase 2]
Phase 2 trial update for apatinib in refractory colorectal cancer (colorectal neoplasms) completed.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: A Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal Cancer [Phase 1, Phase 2]
A study evaluating pyrotinib plus capecitabine in metastatic HER-2 positive colorectal cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Sym004 Versus Futuximab or Modotuximab in Patients With mCRC [Phase 2]
A Phase 2 trial comparing Sym004 with Futuximab or Modotuximab in metastatic colorectal cancer was terminated with posted results in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Pemetrexed and Erlotinib for Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating pemetrexed and erlotinib for metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Perioperative Active Warming Techniques in Colorectal Surgeries [NA]
Clinical trial update on perioperative active warming techniques in colorectal surgeries; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-10Clinical Trial Update: Promoting Veteran-Centered Colorectal Cancer Screening [NA]
Clinical trial update related to veteran-centered colorectal cancer screening; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C) [Phase 2]
Phase 2 study of MK-3475 (pembrolizumab) in MSI-positive and MSI-negative colorectal cancer and MSI-positive non-colorectal cancers has comp…
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial investigating individualized irinotecan dosing in FOLFIRI for first-line metastatic colorectal cancer based on UGT1A1 genetic …
-
FDA approval · 2019-12-18FDA Approved: OXALIPLATIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Oxaliplatin from Fresenius Kabi USA, LLC.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Avastin in Combination With Chemotherapy for RAS Mutant Unresectable Colorectal Liver-limited Metastases [Phase 4]
Phase 4 trial update evaluating Avastin with chemotherapy for RAS-mutant unresectable colorectal liver-limited metastases has completed.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 [Phase 1, Phase 2]
Phase 1/2 trial evaluating CART133 for relapsed/chemo-refractory advanced malignancies completed, across multiple cancers.